Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction
NCT00001531 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 355
Last updated 2008-03-04
Summary
The purpose of this study is to investigate whether the susceptibility of subjects to atherosclerosis is influenced by prior CMV exposure, whether the susceptability to endothelial dysfunction in patients with and in patients without atherosclerosis is influenced by prior CMV exposure.
Conditions
- Arterial Occlusive Diseases
- Atherosclerosis
- Coronary Disease
- Cytomegalovirus Infections
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1996-06-30
- Completion
- 2000-09-30
Countries
- United States
Study Locations
More Related Trials
-
A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients
NCT01753167 ·Status: COMPLETED ·Phase: PHASE2
-
Cytomegalovirus Cell-Mediated Immunity
NCT00815165 ·Status: COMPLETED
-
Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation
NCT00170170 ·Status: COMPLETED
-
Natural History of Cytomegalovirus (CMV) Infection and Disease Among Renal Transplant Recipients
NCT01833416 ·Status: COMPLETED
-
A Trial to Study How the Body Fights Off Cytomegalovirus (CMV) in Hematopoietic Transplant Recipients.
NCT00273143 ·Status: COMPLETED
-
Cytomegalovirus Reactivation in Non Immunocompromised Patients Undergoing Cardiac Surgery
NCT02527291 ·Status: COMPLETED
-
Safety Study of Four Chimera Cytomegalovirus (CMV) Vaccines in Healthy Adult Males 30-50 Years of Age
NCT01195571 ·Status: COMPLETED ·Phase: PHASE1
-
MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus
NCT00237653 ·Status: TERMINATED ·Phase: PHASE3
-
Cell-mediated Immunity for Prevention of CMV Disease
NCT02538172 ·Status: COMPLETED ·Phase: NA
-
The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis
NCT00341172 ·Status: COMPLETED
-
Comparison of Two Test Methods-NASBA and Antigenemia-for Detecting Cytomegalovirus Infection
NCT00001976 ·Status: COMPLETED
-
Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients
NCT01558037 ·Status: COMPLETED
-
Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV
NCT00006145 ·Status: COMPLETED ·Phase: PHASE3
-
AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients
NCT04690933 ·Status: COMPLETED
-
A Study of HIV and Cytomegalovirus (CMV) in HIV-Infected Patients
NCT00001089 ·Status: COMPLETED
-
A Study of Cytomegalovirus Disease Epidemiology in Pediatric and Adult Liver Transplant Recipients in China
NCT05958186 ·Status: COMPLETED
-
Cytomegalovirus Reactivation in ICU Patients Requiring Prolong Mechanical Ventilation
NCT06520605 ·Status: RECRUITING
-
The Link Between Human Cytomegalovirus (HCMV) and Hypertension
NCT01113359 ·Status: UNKNOWN
-
Clinical and Immunological Features of the CMV Infection Atypical Course in Immunocompetent Individuals
NCT04392297 ·Status: COMPLETED
-
Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells
NCT03798301 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine
NCT01357915 ·Status: COMPLETED ·Phase: NA
-
Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients
NCT00436384 ·Status: COMPLETED
-
Immune Response to Cytomegalovirus
NCT00034437 ·Status: COMPLETED
-
Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS
NCT00000693 ·Status: COMPLETED ·Phase: NA
-
Kinetics of Response of Cytomegalovirus With Ganciclovir Treatment Using Quantitative Real-Time PCR
NCT00004573 ·Status: UNKNOWN ·Phase: NA